There's a big diamond in the sky made by connecting the stars Arcturus, Spica, Denebola and Cor Caroli. Once found, you can ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

In CF, Arcturus is advancing an inhalable mRNA therapy, ARCT-032, for which it is running a Phase II trial in patients who ...

Despite a drop in revenue, Arcturus Therapeutics Holdings Inc (ARCT) extends its cash runway to 2028, focusing on critical ...

As spring advances, the night sky undergoes a quiet transformation. The familiar winter constellations fade toward the west, ...

The bright constellations of winter have departed in the west, while the stars of spring are climbing the eastern and ...

Neda Safarzadeh Safarzadeh; Vice President and Head of Investor Relations, Public Relations and Marketing; Arcturus Therapeutics Holdings Inc. Joseph Payne; Presiden ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Monday reported a loss of $14.1 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of ...

As the Army looks to do away with its current pursuit of a future tactical drone, the plan to fill the mission is murky.

Payne reported the recent EU approval of KOSTAIVE, Arcturus' self-amplifying mRNA COVID-19 vaccine, and receipt of an initial milestone payment from CSL. He announced an upcoming marketing ...

During the last three months, 7 analysts shared their evaluations of Arcturus Therapeutics ARCT, revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ...